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Abstract
The nuclear matrix protein, MATR3, is a newly-described Rev cofactor whose mechanism of action is only starting
to be revealed.
Introduction
Retroviruses by necessity have evolved mechanisms to
export unspliced viral genomic and mRNA out of the
nucleus and into the cytoplasm, where they can be trans-
lated or assembled into virions. The first such system dis-
covered was the Rev/Rev Response Element (RRE) system
in HIV-1. The paradigm proposed for Rev/RRE function
[1], whereby interaction of Rev with the RRE (originally
k n o w na sC A R ,f o rC i sA n t i - R e p r e s s o r )o v e r c o m e sc i s
repressor sequences (CRS, or INS - inhibitory sequences)
that otherwise retain unspliced/partially spliced mRNA
within the nucleus, has proven remarkably durable. The
early debates over whether Rev acts by splicing inhibition
(allowing export) or by rapid export (kinetically outracing
splicing and/or degradation), have devolved to a more
complex picture, in which Rev interacts with the RRE and
with CRM-1/exportin 1, which in turn interacts with the
phenylalanine-glycine (FG) repeats of nucleoporins, med-
iating export. Once in the cytoplasm, Rev-dependent
mRNAs, in some systems, may also require Rev for effi-
cient translation (reviewed in [2]). Multiple factors have
been reported to interact directly or indirectly with Rev-
mediated mRNA transport/expression (reviewed in [3]).
Furthermore, proposals for how CRS sequences block
incompletely spliced viral RNA from productive export
have invoked message instability, or message retention -
the latter from suboptimal splicing or binding to nuclear
factors (reviewed in [4]). Whatever the mechanisms
involved, the effects of the Rev/RRE interaction are only
apparent when the mRNA contains CRS/INS sequences.
Discussion
Two papers recently co-published in this journal [5,6]
implicate the nuclear matrix protein, MATR3, as a
co-factor used by the HIV-1 Rev protein to facilitate the
nuclear export and translation of unspliced and partially
spliced viral mRNA. The Marcello group came to this dis-
covery using MS2 coat protein recognition sequence tags
and MS2 pull down to survey host proteins specifically
bound to HIV mRNA. The Jeang lab came to it through a
yeast 2 hybrid survey of proteins that bound to PTB-1
("polypyrimidine tract binding protein-1”), reasoning that,
since PSF (a “PTB-1 associated splicing factor”)i n h i b i t s
the expression of CRS/INS-containing HIV-1 transcripts
[7], other PTB-1 binding proteins, such as MATR3, might
do so as well. Remarkably, these two divergent histories
led to agreement on the facts at hand:
￿ MATR3 binds intracellularly to HIV mRNA.
￿ MATR3 has no direct effect on transcription from
the HIV LTR despite its previous (though admittedly
weak) implication in a role in transcription [8-11].
￿ For maximal function, Rev needs MATR3 to pro-
mote the cytoplasmic accumulation and (presumably
consequent) translation of unspliced (or partially
spliced) RRE-containing mRNA.
￿ Rev, MATR3 and RRE-containing mRNA form a
detectable intracellular complex.
The addition of MATR3 to the pantheon of Rev
c o f a c t o r si st a n t a l i z i n g :M A T R 3e x i s t si nc e l l s ,c o m -
plexed with PSF and nrbp54 [12-15]; PSF binds to CRS/
INS sequences in HIV mRNA and suppresses the
expression of these RNAs ([7]); MATR3 has been identi-
fied as a constituent of the nuclear pore proteome [16].
Consequently, it is tempting to view Rev as working
with MATR3 to free mRNA from CRS retention (by, for
example, PSF), allowing export; or as working with
MATR3 to ferry mRNA to/through the nucleopore. The
two mechanisms need not be mutually exclusive. Correspondence: andrew.dayton@fda.hhs.gov
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any medium, provided the original work is properly cited.Figure 1 Parsimonious kinetic models of Rev export and different mechanisms of CRS/INS function. A) A typical cellular pre-mRNA, with
typical splicing sites, even with a heterologous RRE, is not exported by Rev. B) Introduction of a “retention” or “aberrant splicing” CRS/INS into a
mRNA retards splicing, allowing Rev/RRE export to effectively compete. C) Instability factors inducing degradation might be proposed to interact
directly with CRS/INS, but stability alone without retardation of splicing would still not allow Rev/RRE export the opportunity to compete. D)
Similarly, were Rev/RRE merely to release such an instability factor, rapid splicing would still outcompete Rev/RRE export, as in A. SD, splice
donor; SA, splice acceptor; E#, exon#.
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Page 2 of 3Theoretically, the pre-translational effects of Rev can
be explained entirely by a simple transport mechanism
based on competitive kinetics. The involvement of Rev/
RRE in transport is well documented. What is important
to understand is that, as mentioned above, the effects of
Rev/RRE transport are only seen in the presence of
CRS/INS sequences. The logical consequence of this is
that any Rev mechanism must at least do more than
merely abolish CRS/INS interaction with the binding
partners responsible for repression. Otherwise, Rev
would merely render a target mRNA equivalent to a
typical mRNA which would be rapidly spliced and then
exported. As depicted in Figure 1, splicing of a typical
mRNA, even with an RRE, is too rapid for Rev to inter-
dict (Figure 1A). Any CRS/INS mechanism which makes
export of mRNA Rev-dependent must necessarily retard
splicing (Figure 1B) to allow Rev-export. Though degra-
dation may very well result from delayed splicing, any
CRS mechanism based totally on mRNA instability can
not work, because elimination of the instability would
still allow rapid splicing to outrace Rev-export (Figure 1,
C and 1D). Nevertheless, though parsimony does not
require more than export to be involved in Rev over-
coming CRS/INS inhibition and promoting cytoplasmic
expression of unspliced mRNA, there is nothing to say
that a multifunctional protein such as Rev does not also
get directly involved in prying mRNA from various
interacting partners which would otherwise contribute
to its retention, such as components of aberrant splicing
complexes. How MATR3 fits into any of these scenarios
remains to be determined.
Finally, MATR3 has also been identified as interacting
with the molecular chaperone cluster implicated by
siRNA screening to be involved in viral assembly [17].
This could underlie observations that Rev is involved in
encapsidation (see [18] and [2]).
Conclusions
As is generally the case, the answers to all of these ques-
tions will emerge as more information is obtained con-
cerning Rev/RRE and CRS/INS associated factors and
their normal cellular roles. At the age of 24, the field of
Rev remains rich and productive.
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